Bifodan A/S Introduces Portfolio of Innovative Probiotic Solutions

11 Nov 2013 --- With ProDenta, KIDS-ProDenta and ProFresh, Bifodan A/S is introducing a portfolio of innovative probiotic solutions, designed specifically to support oral health.

Through an increasing number of scientific publications with encouraging conclusions, there is mounting evidence that select probiotic strains with well-defined characteristics can positively contribute to maintain a balanced and healthy micro biota of the oral cavity.

An imbalanced oral micro biota may lead to oral health problems such as caries, gingivitis, periodontitis, and bad breath.

The new ProDenta & ProFresh products represent a novel approach to maintain good tooth and gum health and freshen breath through maintaining a healthy micro biota of the oral cavity though providing a natural defense against oral pathogens, explains Business Development Manager, Niels Peter Bak.

The products contain a proprietary probiotic strain of Lactobacillus salivarius, carefully selected from a large pool of strains, due to its‘ strong capability of effectively suppressing specific oral pathogens linked to caries, gingivitis and bad breath. The screening and selection of probiotic strains were carried out in very close collaboration with leading scientists at Copenhagen University, Department of Odontology.

“Through combining skills in probiotic strain selection with our long standing expertise within development and GMP manufacture of probiotic solutions, we are excited to introduce a portfolio of innovative turn-key probiotic solutions for oral health. The products include a tasty chewable tablet for children‘s tooth health and two lozenges for adults for tooth & gum health and for breath freshening” concludes Niels Peter Bak.

All products are available as turnkey solutions ready to market under the customer’s brand name.

Related Articles

Business News

Lakeview Equity invests in nutritional solutions provider NutriScience Innovations

11 Dec 2017 --- Lakeview Equity Partners, LLC, a US$40 million Milwaukee, US-based private equity fund, has invested in NutriScience Innovations, LLC, based in Trumbull, Connecticut, US. NutriScience is a cGMP-certified global supplier of nutritional and functional ingredients to companies that manufacture nutraceutical, pharmaceutical, food and beverage, and dietary products.

Business News

New Biopolis probiotic mix helps reduce topical steroid use by atopic dermatitis patients

07 Dec 2017 --- Biopolis, majority owned by agricultural processor and food ingredient provider Archer Daniels Midland Company (ADM), has introduced a new probiotic mix designed to reduce the need for topical steroid use by Atopic Dermatitis (AD) patients. The clinical research recently published in JAMA Dermatology, an international peer-reviewed general medical journal, shows the benefits of consuming a mix of probiotics in reducing the need for topical steroids by AD patients.

Business News

Nestle acquires Atrium for US$2.3 billion, extends consumer healthcare portfolio

06 Dec 2017 --- Nestle has agreed to acquire Canadian nutritional health products manufacturer Atrium Innovations from a group of investors led by Permira Funds for US$2.3 billion in cash. Nestle notes that the move for the company, whose 2017 sales are expected to reach almost US$700 million, supports Nestle’s pursuit of growth opportunities in consumer healthcare to complement the company's focus on its high-growth food and beverage categories.

Nutrition & Health News

DuPont’s Microbiome Venture aims to lead development of new microbiome science-based solutions

30 Nov 2017 --- DuPont Nutrition & Health has announced the development of what it describes as a “significant new initiative” with the creation of its Microbiome Venture to spearhead the development of new microbiome science-based solutions. The Microbiome Venture will play a key role in DuPont’s business growth strategy.

Nutrition & Health News

Modifying gut microbiome may eventually prevent asthma in infant boys

29 Nov 2017 --- The family risk for asthma – typically passed from mothers to babies – may involve the microbes found in a baby's digestive tract. This is according to a new University of Alberta study, funded by the Canadian Institutes of Health Research (CIHR) and AllerGen and published in the European Respiratory Journal.

More Articles
URL : http://www.nutritioninsight.com:80/news/bifodan-as-introduces-portfolio-of-innovative-probiotic-solutions.html